By Dave Sebastian

Medtronic PLC raised the lower end of its adjusted per-share earnings guidance range for fiscal 2022 and reiterated its revenue growth outlook as Chief Executive Geoff Martha said the company has seen "continued procedure volume recovery, with most of our businesses at or above pre-Covid levels."

The medical-technology company on Tuesday said it expects full-year adjusted earnings of $5.65 a share to $5.75 a share, up from its prior outlook of $5.60 a share to $5.75 a share.

The company continues to expect revenue growing about 9% on an organic basis for the year.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

August 24, 2021 07:16 ET (11:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.